Here's how FRONTIERSIN.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

FRONTIERSIN . ORG {}

Detected CMS Systems:

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Frontiersin.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. Social Networks
  11. External Links
  12. Libraries
  13. Hosting Providers

We are analyzing https://www.frontiersin.org/journals/immunology/for-authors/submission-checklist.

Title:
Frontiers in Immunology | About
Description:
The official journal of the International Union of Immunological Societies (IUIS) and the most cited in its field, leading the way for research across basic, translational and clinical immunology.
Website Age:
19 years and 4 months (reg. 2006-02-11).

Matching Content Categories {📚}

  • Books & Literature
  • Non-Profit & Charity
  • Careers

Content Management System {📝}

What CMS is frontiersin.org built with?


Frontiersin.org is built with TYPESETTER CMS.

Traffic Estimate {📈}

What is the average monthly size of frontiersin.org audience?

🌍 Impressive Traffic: 500k - 1M visitors per month


Based on our best estimate, this website will receive around 600,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Frontiersin.org Make Money? {💸}

We don’t know how the website earns money.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Frontiersin.org might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

manuscript, submission, frontiers, authors, research, guidelines, file, author, requested, data, article, details, provide, information, statement, source, figures, articles, submit, editorial, checklist, submitting, follow, ensure, submitted, types, added, contribution, generated, prepare, statements, editor, publication, funding, institution, policy, journals, topics, journal, process, scope, type, required, questions, consent, relevant, emails, tex, rights, cover,

Topics {✒️}

published/adapted/modified/partial figures editorial office author guidelines journal/section/research topic manuscript guidelines article types correct article type wrong article type alerts contact research search frontiers editor party rights holders checklist detailing articles submit rgb color mode community-supported repositories including grant numbers relevant ethical approval traditional cover letter mention funds received author information citation instructions requested submitting author identifiable human data data availability statement types prepare details ahead frontiers requires journals author frontiers manuscript submission process publication journal pages data statement statement summarizing funding section relevant tab file requirements source file bib file uploaded figures frontiers main content potentially rejection additional details jpeg formats supplementary charges directly inserted source form

Questions {❓}

  • Why submit?

Schema {🗺️}

Periodical:
      context:http://schema.org
      id:https://www.frontiersin.org/journals/immunology
      issn:
         1664-3224
      hasPart:
            id:https://www.frontiersin.org/journals/immunology/sections/alloimmunity-and-transplantation
            type:PublicationIssue
            id:https://www.frontiersin.org/journals/immunology/sections/antigen-presenting-cell-biology
            type:PublicationIssue
            id:https://www.frontiersin.org/journals/immunology/sections/autoimmune-and-autoinflammatory-disorders-autoimmune-disorders
            type:PublicationIssue
            id:https://www.frontiersin.org/journals/immunology/sections/autoimmune-and-autoinflammatory-disorders-autoinflammatory-disorders
            type:PublicationIssue
            id:https://www.frontiersin.org/journals/immunology/sections/b-cell-biology
            type:PublicationIssue
            id:https://www.frontiersin.org/journals/immunology/sections/cancer-immunity-and-immunotherapy
            type:PublicationIssue
            id:https://www.frontiersin.org/journals/immunology/sections/comparative-immunology
            type:PublicationIssue
            id:https://www.frontiersin.org/journals/immunology/sections/cytokines-and-soluble-mediators-in-immunity
            type:PublicationIssue
            id:https://www.frontiersin.org/journals/immunology/sections/immunological-memory
            type:PublicationIssue
            id:https://www.frontiersin.org/journals/immunology/sections/immunological-tolerance-and-regulation
            type:PublicationIssue
            id:https://www.frontiersin.org/journals/immunology/sections/inflammation
            type:PublicationIssue
            id:https://www.frontiersin.org/journals/immunology/sections/microbial-immunology
            type:PublicationIssue
            id:https://www.frontiersin.org/journals/immunology/sections/molecular-innate-immunity
            type:PublicationIssue
            id:https://www.frontiersin.org/journals/immunology/sections/mucosal-immunity
            type:PublicationIssue
            id:https://www.frontiersin.org/journals/immunology/sections/multiple-sclerosis-and-neuroimmunology
            type:PublicationIssue
            id:https://www.frontiersin.org/journals/immunology/sections/nk-and-innate-lymphoid-cell-biology
            type:PublicationIssue
            id:https://www.frontiersin.org/journals/immunology/sections/nutritional-immunology
            type:PublicationIssue
            id:https://www.frontiersin.org/journals/immunology/sections/parasite-immunology
            type:PublicationIssue
            id:https://www.frontiersin.org/journals/immunology/sections/primary-immunodeficiencies
            type:PublicationIssue
            id:https://www.frontiersin.org/journals/immunology/sections/systems-immunology
            type:PublicationIssue
            id:https://www.frontiersin.org/journals/immunology/sections/t-cell-biology
            type:PublicationIssue
            id:https://www.frontiersin.org/journals/immunology/sections/vaccines-and-molecular-therapeutics
            type:PublicationIssue
            id:https://www.frontiersin.org/journals/immunology/sections/viral-immunology
            type:PublicationIssue
      name:Frontiers in Immunology
      about:Frontiers in Immunology is a multidisciplinary journal that publishes research across basic, translational, and clinical immunology. The journal showcases advances and novel approaches to diagnosing and treating immune disorders in both animal and cellular models, as well as in humans. Indexed in MEDLINE, PubMed Central, Scopus and the SCIE Frontiers in Immunology is the official Journal of the International Union of Immunological Societies (IUIS). Led by Field Chief Editor Pietro Ghezzi (Emeritus Professor at Brighton and Sussex Medical School), Frontiers in Immunology welcomes contributions that investigate the basic mechanisms of immune system development and function, with a particular emphasis on describing the clinical and immunological phenotype of human immune disorders and defining their molecular basis. Topics include: advances in biological drugs immune system development and function molecular basis of human immune disorders novel approaches to diagnosis and treatment of immune disorders precision medicine for immunological disorders studies on animal and cellular models and in humans studies on systems immunology with relevant experimental validation. Frontiers in Immunology particularly welcomes news ideas and approaches which supports and advances the UN’s Sustainable Development Goal (SDGs), specifically SDG 3: good health and well-being. The research published in this journal could lead to the development of new treatments and therapies for various immunological disorders, thereby promoting well-being for all. Manuscripts that focus on clinical studies, medical treatments, or human diseases without a clear connection to immunology are not suitable for publication in this journal. Additionally, studies that use analytical molecular biology techniques without a clear immunological context or contribution to the field of immunology are also not within the scope of this journal. Frontiers’ journals require that manuscripts primarily comprising computational studies of public data, must include appropriate validation. Please refer to the Frontiers Standards for research methodology policy, for more information. Manuscripts not adhering to these standards will not be considered. Frontiers in Immunology is dedicated to propelling advancements in the field of Immunology by providing unrestricted access to articles and disseminating scientific knowledge to researchers and the public. This enables future scientific breakthroughs. Ethics Statement All manuscripts submitted to Frontiers in Immunology that have been conducted in human subjects must conform with current regulations and the Declaration of Helsinki. Ethics committee approval and informed patient consent are required for studies involving human subjects. Institutional animal care and use committee (IACUC) approval is needed for studies involving animals. Phase I - Phase IV clinical trials submitted for publication in Frontiers in Immunology must have been registered with an appropriate public trials registry at the time or before the first patient enrolment. The information on the clinical trial registration (Unique Identifier and URL) must be included in the abstract. Authors are required to disclose all apparent or potential conflicts of interest according to the ICMJE guidelines and those of Frontiers.
      publisher:
         id:https://www.frontiersin.org/#organization
         type:NewsMediaOrganization
      editor:
            id:https://loop.frontiersin.org/people/22645/overview
            type:Person
            name:Pietro Ghezzi
            jobTitle:Field Chief Editor
            affiliation:
               type:Organization
               name:Brighton and Sussex Medical School
               location:
                  type:Place
                  address:
                     type:PostalAddress
                     addressLocality:Brighton
                     addressCountry:United Kingdom
      inLanguage:en
      datePublished:
      license:CC BY 4.0
      thumbnailUrl:https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/B8A9338D-D05F-42BE-A5B9BE8019A37824/9E25A9DF-C19F-4EE7-BB49ABF77C60D019/WebsiteWebP_M-FIMMU_Main Visual_Red_Website.webp
      url:https://www.frontiersin.org/journals/immunology
PublicationIssue:
      id:https://www.frontiersin.org/journals/immunology/sections/alloimmunity-and-transplantation
      id:https://www.frontiersin.org/journals/immunology/sections/antigen-presenting-cell-biology
      id:https://www.frontiersin.org/journals/immunology/sections/autoimmune-and-autoinflammatory-disorders-autoimmune-disorders
      id:https://www.frontiersin.org/journals/immunology/sections/autoimmune-and-autoinflammatory-disorders-autoinflammatory-disorders
      id:https://www.frontiersin.org/journals/immunology/sections/b-cell-biology
      id:https://www.frontiersin.org/journals/immunology/sections/cancer-immunity-and-immunotherapy
      id:https://www.frontiersin.org/journals/immunology/sections/comparative-immunology
      id:https://www.frontiersin.org/journals/immunology/sections/cytokines-and-soluble-mediators-in-immunity
      id:https://www.frontiersin.org/journals/immunology/sections/immunological-memory
      id:https://www.frontiersin.org/journals/immunology/sections/immunological-tolerance-and-regulation
      id:https://www.frontiersin.org/journals/immunology/sections/inflammation
      id:https://www.frontiersin.org/journals/immunology/sections/microbial-immunology
      id:https://www.frontiersin.org/journals/immunology/sections/molecular-innate-immunity
      id:https://www.frontiersin.org/journals/immunology/sections/mucosal-immunity
      id:https://www.frontiersin.org/journals/immunology/sections/multiple-sclerosis-and-neuroimmunology
      id:https://www.frontiersin.org/journals/immunology/sections/nk-and-innate-lymphoid-cell-biology
      id:https://www.frontiersin.org/journals/immunology/sections/nutritional-immunology
      id:https://www.frontiersin.org/journals/immunology/sections/parasite-immunology
      id:https://www.frontiersin.org/journals/immunology/sections/primary-immunodeficiencies
      id:https://www.frontiersin.org/journals/immunology/sections/systems-immunology
      id:https://www.frontiersin.org/journals/immunology/sections/t-cell-biology
      id:https://www.frontiersin.org/journals/immunology/sections/vaccines-and-molecular-therapeutics
      id:https://www.frontiersin.org/journals/immunology/sections/viral-immunology
NewsMediaOrganization:
      id:https://www.frontiersin.org/#organization
Person:
      id:https://loop.frontiersin.org/people/22645/overview
      name:Pietro Ghezzi
      jobTitle:Field Chief Editor
      affiliation:
         type:Organization
         name:Brighton and Sussex Medical School
         location:
            type:Place
            address:
               type:PostalAddress
               addressLocality:Brighton
               addressCountry:United Kingdom
Organization:
      name:Brighton and Sussex Medical School
      location:
         type:Place
         address:
            type:PostalAddress
            addressLocality:Brighton
            addressCountry:United Kingdom
Place:
      address:
         type:PostalAddress
         addressLocality:Brighton
         addressCountry:United Kingdom
PostalAddress:
      addressLocality:Brighton
      addressCountry:United Kingdom

Libraries {📚}

  • AOS
  • Isotope
  • Semantic UI

Emails and Hosting {✉️}

Mail Servers:

  • frontiersin-org.mail.protection.outlook.com

Name Servers:

  • ns1-38.azure-dns.com
  • ns2-38.azure-dns.net
  • ns3-38.azure-dns.org
  • ns4-38.azure-dns.info
7.59s.